 |
|
The Current Evaluation of Nonpalpable Breast Lesions
Nicholas P. Lang, MD;
Gary E. Talbert, MD;
Kris B. Shewmake, MD;
Wilma C. Diner, MD;
David Weiss, MD;
Frank G. Bivins;
Kent C. Westbrook, MD
Arch Surg. 1987;122(12):1389-1391.
Abstract
• To understand the suspected low yield of malignant neoplasms from biopsies guided by needle localization, we reviewed 122 biopsies performed from January 1985 to November 1986 at University Hospital and Arkansas Baptist Medical Center, Little Rock. The positive biopsy rates were 3.5% and 10.6%, respectively. After review of these cases, the following guidelines for biopsy were developed: (1) Do not perform a biopsy on a low-density mass less than 1 cm in diameter. (2) Do not perform a biopsy for asymmetric density or questionable mass. (3) Do not perform a biopsy for secondary signs of malignancy such as skin thickening or asymmetric vasculature. (4) Biopsy is indicated for clustered calcifications, a dominant mass greater than 1 cm in diameter, stellate lesions, or interval change from a previous mammogram. These changes resulted in a positive biopsy rate of 15% for the period from November 1986 through April 1987.
(Arch Surg 1987;122:1389-1391)
Author Affiliations
From the Departments of Surgery (Drs Lang, Talbert, Weiss, and Westbrook) and Radiology (Drs Diner and Weiss and Mr Bivins), University of Arkansas for Medical Sciences, Little Rock.
Footnotes
Accepted for publication Aug 24, 1987.
Read before the Annual Meeting of the Society of Surgical Oncology, London, April 27, 1987.
Reprint requests to UAMS, Department of Surgery, Slot 520, 4301 W Markham, Little Rock, AR 72205 (Dr Lang).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Breast Biopsy for Calcifications in Nonpalpable Breast Lesions: A Prospective Study
Franceschi et al.
Arch Surg 1990;125:170-173.
ABSTRACT
|
